SOURCE: CLX Investment Company, Inc.

January 22, 2008 09:23 ET

CLX Investment Company Announces Secure Storage of Zonda Chlamydia Tests with Sentry Logistic Solutions in Preparation for Clinical Trails

MURRIETA, CA--(Marketwire - January 22, 2008) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that in preparation for planned clinical trials for Zonda's rapid point of care test for Chlamydia, the tests that will be used in the trials have been placed in an FDA compliant, GMP approved secure storage facility provided by Sentry Logistic Solutions ("Sentry"), a leading provider of temperature-controlled storage and third party logistics.

Sentry offers refrigerated, ambient, frozen and ultra low storage, logistics and distribution services for a broad range of clinical and commercial biopharmaceutical materials and components. Its experienced staff and 53,000 square-foot facility can handle virtually any storage need and enhance a client's supply chain capabilities.

In anticipation of the initiation of clinical trials scheduled for the mid- to late-1st calendar quarter of 2008, Sentry has received a sufficient supply of Chlamydia tests in bulk and will disseminate them for use in the trials as appropriate. Sentry will also provide additional services related to the storage and distribution of the tests including cold chain logistics, labeling and packaging.

For additional details regarding Sentry's capabilities and services, please visit

"We are pleased to have Sentry Logistic Solutions involved with the scheduled clinical trials for the Zonda Chlamydia test," said Vera Leonard, chief executive officer of Zonda and CLX. "Sentry has the facilities and the resources necessary to ensure that the Chlamydia tests are property stored, labeled and distributed before and during the trials. We look forward to establishing a good working relationship with Sentry as we position CLX to potentially acquire, license and/or distribute additional medical diagnostic testing products."

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit

About Sentry Logistic Solutions

Sentry Logistic Solutions is one of the few cGMP temperature-controlled storage and third party logistics (3PL) providers in the United States to exclusively serve the global pharmaceutical, biotechnology and health care industries. Its facilities, infrastructure and services are specifically designed to meet the warehousing, packaging and logistics needs of pharma and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and government entities.

Sentry's management team offers expertise in cold chain storage and logistics, quality assurance, pharmaceutical packaging and kitting development. Sentry also offers strategic solutions for domestic and international transportation and logistics as well as end-to-end import and export management. The company's validated processes and inventory tracking systems are FDA compliant, adhere to Good Manufacturing Practice (GMP) and comply with stringent standard operating procedures (SOP) outlined in Sentry's Validation Master Plan. Sentry is VAWD® accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Board of Pharmacy®. The company is privately held and strategically headquartered in Indianapolis, Ind. For more information about the company, please visit or call (866) 757-7400.

About CLX Investment Company

CLX Investment Company ( holds a 51% equity interest in Zonda, Inc. CLX has also invested, and holds a common stock position, in ActionView International, Inc. (, a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contacts:
    For CLX Investment Company:
    Gemini Financial Communications
    A. Beyer
    Email Contact

    For Sentry Logistic Solutions:
    Rachel Edwards
    Synergy Marketing Group, Inc.
    (317) 205-9690 ext. 227
    Email Contact